Not applicableStudy completedNCT05062135What this trial is testingProgesterone Action on Endometrium of PCOSWho this might be right forPolycystic OvaryProgesterone Resistance University of Sao Paulo General Hospital 36
Early research (Phase 1)Ended earlyNCT06264921What this trial is testingA Study With NKT3447 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more NiKang Therapeutics, Inc. 23
Post-approval studies (Phase 4)Study completedNCT03930212What this trial is testingProgesterone Supplementation in Threatened AbortionWho this might be right forThreatened AbortionProgesterone Resistance Tanta University 190
Not applicableStudy completedNCT01385280What this trial is testingPilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Cancer+2 more University of Arizona 13
Not applicableActive Not RecruitingNCT03756480What this trial is testingCancer Driving Mutations in Endometriosis Lesions and Development of Progesterone ResistanceWho this might be right forEndometriosisEndometrial Diseases Johns Hopkins University 135
Not applicableStudy completedNCT03519776What this trial is testingVariation of Progesterone in IVF CyclesWho this might be right forProgesterone Resistance ART Fertility Clinics LLC 30
Early research (Phase 1)Active Not RecruitingNCT04052555What this trial is testingTesting the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast CancerWho this might be right forBilateral Breast CarcinomaHER2-Negative Breast CarcinomaLocalized Breast Carcinoma+2 more National Cancer Institute (NCI) 42
Early research (Phase 1)Looking for participantsNCT06586957What this trial is testingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more NiKang Therapeutics, Inc. 150
Early research (Phase 1)Study completedNCT02152943What this trial is testingEverolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsWho this might be right forAdvanced Malignant Solid NeoplasmEstrogen Receptor PositiveHER2/Neu Positive+10 more M.D. Anderson Cancer Center 37
Very early researchStudy completedNCT03356964What this trial is testingStep Down FSH Approach and Late Follicular Phase in Progesterone LevelWho this might be right forProgesterone Resistance ART Fertility Clinics LLC 127
Early research (Phase 1)Not Yet RecruitingNCT07173361What this trial is testingProgesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)Who this might be right forHealthy VolunteersFemaleProgesterone+1 more McMaster University 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06390904What this trial is testingGnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia PatientsWho this might be right forAtypical Endometrial HyperplasiaProgesterone ResistanceObesity Xiaojun Chen 29
Testing effectiveness (Phase 2)Study completedNCT01831076What this trial is testingPreoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 TumorsWho this might be right forBreast CancerStage II Breast CancerStage III Breast Cancer University of Colorado, Denver 36
Testing effectiveness (Phase 2)Study completedNCT00118157What this trial is testingLapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous TamoxifenWho this might be right forEstrogen Receptor PositiveMale Breast CarcinomaProgesterone Receptor Positive+4 more National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT01197170What this trial is testingHormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceWho this might be right forSolid TumorsAdvanced Cancer M.D. Anderson Cancer Center 277
Early research (Phase 1)WithdrawnNCT02567396What this trial is testingTalazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWho this might be right forEstrogen Receptor NegativeHead and Neck Squamous Cell CarcinomaHER2/Neu Negative+20 more National Cancer Institute (NCI)
Not applicableLooking for participantsNCT06414720What this trial is testingSalivary microRNA in Endometriosis: Correlation With Response to Progestin TherapyWho this might be right forEndometriosis University of Udine 90
Testing effectiveness (Phase 2)WithdrawnNCT04184323What this trial is testingSIRT-1 Antagonism for Endometrial ReceptivityWho this might be right forEndometriosisUterine DiseasesEndometrial Diseases+2 more Wake Forest University Health Sciences
Not applicableUnknownNCT04163380What this trial is testingResistance Training and Sex Hormone Concentrations During the Menstrual CycleWho this might be right forWomen's Health Southern Illinois University Edwardsville 25